Concepedia

Cristina Tacu

CT

Statistics

Publications

3

Citations

130

H-Index

3

Active since

2021

Affiliations

Manchester University NHS Foundation Trust(Current)

University of Nottingham

Manchester Academic Health Science Centre

Oxford BioMedica (United Kingdom)

Harefield Hospital

Cristina Tacu is an author at Manchester University NHS Foundation Trust specializing in inflammation, immunology, and vaccine efficacy.

ORCID

Publications per year

2021–2023

3

Publications

3

Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a randomised, open label, superiority trial

Abhishek Abhishek, Rosemary J. Boyton, Nicholas Peckham et al. · The Lancet Respiratory Medicine · 2022 · 81 citations · Full text

, , +17

Secukinumab as a potential trigger of inflammatory bowel disease in ankylosing spondylitis or psoriatic arthritis patients

Ioana Onac, Benjamin D Clarke, Cristina Tacu et al. · Lara D. Veeken · 2021 · 29 citations

, , +16

Effect of a 2-week interruption in methotrexate treatment on COVID-19 vaccine response in people with immune-mediated inflammatory diseases (VROOM study): a randomised, open label, superiority trial

Abhishek Abhishek, Nicholas Peckham, Corinna Pade et al. · The Lancet Rheumatology · 2023 · 20 citations · Full text

, , +17

1–3 of 3